Advertisement
U.S. markets closed
  • S&P Futures

    5,304.25
    -4.00 (-0.08%)
     
  • Dow Futures

    40,140.00
    -36.00 (-0.09%)
     
  • Nasdaq Futures

    18,465.00
    -38.75 (-0.21%)
     
  • Russell 2000 Futures

    2,145.20
    +6.80 (+0.32%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0778
    -0.0015 (-0.14%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • Vix

    13.01
    +0.23 (+1.80%)
     
  • GBP/USD

    1.2621
    -0.0001 (-0.01%)
     
  • USD/JPY

    151.2880
    -0.0840 (-0.06%)
     
  • Bitcoin USD

    70,781.12
    +1,283.13 (+1.85%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,407.92
    +239.85 (+0.60%)
     

Housing Starts, Building Permits Mixed; Q2 for BAC, USB, ABT

Wednesday, July 17, 2019

Housing Starts and Building Permits for June — metrics that are essential for tracking overall domestic economic growth — came in mixed this morning. The headline read for new Housing Starts reached 1.253 million seasonally adjusted, annualized units, higher than the 1.244 million expected. This offsets the slightly downwardly revised 1.265 million units from the previous month.

Building Permits, a forward indicator for future starts, reached just 1.22 million last month — well below the 1.3 million analysts were looking for. Revisions for May were slightly higher, to 1.299 million. This marks a drop of 6.1% in permits for June, compared with the -0.3% expected.

Looking beneath the headlines, new housing for multi-family units was the drag on these monthly results; single-family homebuilding actually rose 3.5%. On the permits side, multi-family units also came in light of expectations, while single-family showed slight growth sequentially.

Considering current low interest rates — with a possible Fed rate cut coming at the end of the month — these flaccid numbers are somewhat unexpected. Unless homebuyers are waiting for another leg down on mortgage rates once the rate cut takes effect, we may be seeing some demand concerns in the housing sector.

Q2 Earnings, Continued

Following a string of big Wall Street banks reporting earnings already this week, Bank of America BAC beat estimates by 4 cents per share to 74 cents in its Q2 earnings report, above the 63 cents reported in the year-ago quarter. Revenues of $23.08 billion beat expectations by 50 basis points, and are up from $22.61 billion in Q2 2018. Shares are down slightly in today’s pre-market. For more on BAC’s earnings, click here.

U.S. Bancorp USB also put up slight beats on its Q2 earnings and revenues: $1.09 per share versus $1.07 expected, and $5.8 billion versus $5.7 billion anticipated, respectively. Average earnings assets rose 3.5% in the company’s Q2. For more on USB’s earnings, click here.

Abbott Labs ABT was slightly mixed in its Q2 earnings report: 82 cents per share topped by two cents while revenues of $7.98 billion came in 10 basis points shy of the Zacks consensus. Shares are up 1 2/3% a half hour before the opening bell. For more on ABT’s earnings, click here.

Mark Vickery
Senior Editor

Questions or comments about this article and/or its author? Click here>>

Radical New Technology Creates $12.3 Trillion Opportunity

Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.

Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.
 
See the 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
U.S. Bancorp (USB) : Free Stock Analysis Report
 
Bank of America Corporation (BAC) : Free Stock Analysis Report
 
Abbott Laboratories (ABT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
 
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Advertisement